Results 141 to 150 of about 344,744 (207)

Synthesis and Bioactive Properties of the Novel Coloured Compound Obtained via the Laccase-Mediated Transformation of 5-Aminosalicylic Acid. [PDF]

Molecules
Polak J, Grąz M, Szałapata K, Kapral-Piotrowska J, Wlizło K, Polak M, Jarosz-Wilkołazka A.   +6 more
europepmc   +1 more source

Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid. [PDF]

Intern Med
Hayashi D, Nishida T, Osugi N, Kusunoki Y, Okabe S, Fujii Y, Nakamatsu D, Matsumoto K, Yamamoto M, Fukui K.   +9 more
europepmc   +1 more source

Efficacy and safety of Chinese patent medicine combined with 5-aminosalicylic acid for patients with ulcerative colitis: A network meta-analysis of randomized controlled trials. [PDF]

Heliyon
Zhang M, Su Y, Gao Q, Zhou M, Xing Y, Chen Z, Liu X, Li Z, Geng X, Cao G, Zhang H, Wei S.   +11 more
europepmc   +1 more source

Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. [PDF]

Vaccines (Basel)
Shehab M, Alrashed F, Alyaseen M, Safar Z, Adekunle T, Alfadhli A, Bessissow T.   +6 more
europepmc   +1 more source

Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database.

Digestion
Ota T, Takebe T, Shimizu Y, Orido T, Tanaka H, Nakamura S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Disposition of 5-Aminosalicylic Acid by 5-Aminosalicylic Acid-Delivering Compounds

Scandinavian Journal of Gastroenterology, 1988
The disposition of 5-aminosalicylic acid (5-ASA) from 5-ASA-delivering drugs was studied in eight healthy volunteers. Time-related urinary excretion and faecal excretion of 5-ASA and acetyl-5-ASA were measured after a single oral dose of the azo compounds sulphasalazine and olsalazine, of the slow-release compounds Pentasa, Asacol, and Salofalk, and of
J H Van Tongeren
exaly   +4 more sources

Derivatives of 4- or 5-aminosalicylic acid

, 2009
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) and for the prevention/treatment of
J. L. WALLACE, G. CIRINO, G. CALIENDO, A. SPARATORE, V. SANTAGADA, S. FIORUCCI   +5 more
openaire   +2 more sources

Determination of 5‐Aminosalicylic Acid by Catalase‐Peroxidase Based Biosensor

Electroanalysis, 2009
5-Aminosalicylic acid is an anti inflammatory drug used to treat inflammation of the digestive tract (Crohn's disease) and mild to moderate ulcerative-colitis. 5-Aminosalicylic acid is a bowel-specific aminosalicylate drug.
Alper Akkaya, Nurdan Kasikara Pazarlioglu, Erhan Dinçkaya   +2 more
exaly   +2 more sources

Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid

Digestive Diseases and Sciences, 1987
The possible effect of sulfasalazine, 5-aminosalicylic acid, and acetyl-5-aminosalicylic acid on endogenous arachidonic acid release and metabolism was studied in human polymorphonuclear leukocytes (PMNs).
Ole Haagen Nielsen, K Bukhave, J Elmgreen   +2 more
exaly   +1 more source